CVS Health Corporation Company Profile (NYSE:CVS)

About CVS Health Corporation (NYSE:CVS)

CVS Health Corporation logoCVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc. (Omnicare) and Omnicare's long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. It operates through three segments: Pharmacy Services, Retail/LTC and Corporate. The Pharmacy Services Segment provides a range of pharmacy benefit management (PBM) solutions to its clients. As of December 31, 2016, the Retail/LTC Segment included 9,709 retail locations (of which 7,980 were its stores that operated a pharmacy and 1,674 were its pharmacies located within Target Corporation (Target) stores), its online retail pharmacy Websites,, and, 38 onsite pharmacy stores, its long-term care pharmacy operations and its retail healthcare clinics.

Industry, Sector and Symbol:
  • Sector: Retail/Wholesale
  • Industry: Drug Retailers
  • Sub-Industry: Drug Retail
  • Symbol: NYSE:CVS
  • CUSIP: 12665010
  • Web:
  • Market Cap: $75.33 billion
  • Outstanding Shares: 1,016,564,000
Average Prices:
  • 50 Day Moving Avg: $79.27
  • 200 Day Moving Avg: $78.87
  • 52 Week Range: $69.30 - $88.84
  • Trailing P/E Ratio: 14.47
  • Foreward P/E Ratio: 11.67
  • P/E Growth: 1.46
Sales & Book Value:
  • Annual Revenue: $180.79 billion
  • Price / Sales: 0.42
  • Book Value: $33.64 per share
  • Price / Book: 2.20
  • Annual Dividend: $2.00
  • Dividend Yield: 2.5%
  • EBITDA: $12.65 billion
  • Net Margins: 2.93%
  • Return on Equity: 17.47%
  • Return on Assets: 6.58%
  • Debt-to-Equity Ratio: 0.75%
  • Current Ratio: 1.09%
  • Quick Ratio: 0.56%
  • Average Volume: 5.43 million shs.
  • Beta: 0.92
  • Short Ratio: 3.89

Frequently Asked Questions for CVS Health Corporation (NYSE:CVS)

What is CVS Health Corporation's stock symbol?

CVS Health Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

How often does CVS Health Corporation pay dividends? What is the dividend yield for CVS Health Corporation?

CVS Health Corporation declared a quarterly dividend on Tuesday, September 19th. Shareholders of record on Tuesday, October 24th will be given a dividend of $0.50 per share on Friday, November 3rd. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.70%. The ex-dividend date of this dividend is Monday, October 23rd. View CVS Health Corporation's Dividend History.

How were CVS Health Corporation's earnings last quarter?

CVS Health Corporation (NYSE:CVS) posted its quarterly earnings data on Tuesday, August, 8th. The company reported $1.33 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $1.31 by $0.02. The business had revenue of $45.69 billion for the quarter, compared to the consensus estimate of $45.36 billion. CVS Health Corporation had a return on equity of 17.47% and a net margin of 2.93%. The company's revenue was up 4.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.32 EPS. View CVS Health Corporation's Earnings History.

When will CVS Health Corporation make its next earnings announcement?

CVS Health Corporation is scheduled to release their next quarterly earnings announcement on Monday, November, 6th 2017. View Earnings Estimates for CVS Health Corporation.

What guidance has CVS Health Corporation issued on next quarter's earnings?

CVS Health Corporation updated its FY17 earnings guidance on Tuesday, August, 8th. The company provided earnings per share (EPS) guidance of $5.83-5.93 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.87. CVS Health Corporation also updated its Q3 guidance to $1.47-1.50 EPS.

Where is CVS Health Corporation's stock going? Where will CVS Health Corporation's stock price be in 2017?

21 brokers have issued 1-year price targets for CVS Health Corporation's stock. Their predictions range from $82.00 to $111.00. On average, they anticipate CVS Health Corporation's share price to reach $89.82 in the next year. View Analyst Ratings for CVS Health Corporation.

What are analysts saying about CVS Health Corporation stock?

Here are some recent quotes from research analysts about CVS Health Corporation stock:

  • 1. Guggenheim analysts commented, " Our recent meetings with CEO Larry Merlo, CFO Dave Denton, and VP-IR Nancy Christal further reinforced our confidence in 10% secular growth, which we believe the market is currently undervaluing, at a 13x P/E on somewhat depressed 2017E EPS. Bottom line, even in the face of secular gross margin erosion, in both segments, we believe the company should be able to grow EBIT by 5% on the back of a) natural growth in specialty Rx, b) increasingly rapid product innovation, c) a broadening set of productive relationships, and d) both COGS and SG&A reductions. In our view, this growth merits a valuation closer to a market multiple'we reiterate our Buy rating and $90 PT, implying 15% upside from current levels." (3/28/2017)
  • 2. Evercore ISI analysts commented, "While the quarter proved generally uneventful and guidance was reiterated on the surface (albeit some moving parts below ' dollar profit targets were unchanged in our view ' much of the delta related to where 4Q came out vs mid-point and lower inflation outlook), investors have reacted negatively to the lack of clarity on several key issues with respect to business model risk that in our minds is unlikely to dissipate until later in the year. We think management did an admirable job on the DIR fee issue and a reasonable job on gross to net / rebates, but the reality is that policy noise is unlikely to dissipate and the outlook for 2018 won't start to gain clarity until the summer. We think once we get initial color on the PBM selling season, a better understanding of underlying pharmacy share shifts and profit headwinds and ultimately gain a better picture of 2018 the multiple may start to see some relief. Until then CVS shares remain inexpensive and highly leveraged to tax reform and it appears as if many years of execution are being overshadowed by a tough 18 month stretch. Given how far shares have fallen and in our view strong FCF yield support we retain our Buy rating but acknowledge the path to returns from here is likely most appropriate for those with a multi-year time horizon and a 'deep value' focus." (2/9/2017)

Who are some of CVS Health Corporation's key competitors?

Who are CVS Health Corporation's key executives?

CVS Health Corporation's management team includes the folowing people:

  • David Wyatt Dorman, Independent Chairman of the Board
  • Larry J. Merlo, President, Chief Executive Officer, Director
  • David M. Denton, Chief Financial Officer, Executive Vice President
  • Jonathan C. Roberts, Chief Operating Officer, Executive Vice President
  • Lisa G. Bisaccia, Chief Human Resource Officer, Executive Vice President
  • Stephen J. Gold, Executive Vice President, Chief Information Officer
  • Thomas M. Moriarty, Executive Vice President, General Counsel, Chief Health Strategy Officer
  • Troyen A. Brennan M.D., Executive Vice President, Chief Medical Officer
  • Helena B. Foulkes, Executive Vice President, President of CVS - Pharmacy
  • J. David Joyner, Executive Vice President

Who owns CVS Health Corporation stock?

CVS Health Corporation's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Cacti Asset Management LLC (0.06%), Tandem Investment Advisors Inc. (0.01%), Beacon Financial Group (0.01%), Pensionfund DSM Netherlands (0.01%), First National Bank of Mount Dora Trust Investment Services (0.00%) and Pensionfund Sabic (0.00%). Company insiders that own CVS Health Corporation stock include Andrew Sussman, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Larry J Merlo, Richard J Swift, Stephen J Gold, Thomas M Moriarty and Troyen A Brennan. View Institutional Ownership Trends for CVS Health Corporation.

Who sold CVS Health Corporation stock? Who is selling CVS Health Corporation stock?

CVS Health Corporation's stock was sold by a variety of institutional investors in the last quarter, including First National Bank of Mount Dora Trust Investment Services and Bath Savings Trust Co. Company insiders that have sold CVS Health Corporation stock in the last year include Andrew Sussman, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Larry J Merlo, Richard J Swift, Thomas M Moriarty and Troyen A Brennan. View Insider Buying and Selling for CVS Health Corporation.

Who bought CVS Health Corporation stock? Who is buying CVS Health Corporation stock?

CVS Health Corporation's stock was acquired by a variety of institutional investors in the last quarter, including Cacti Asset Management LLC, Tandem Investment Advisors Inc., Pensionfund DSM Netherlands, Pensionfund Sabic, Curbstone Financial Management Corp, Fulton Bank N.A. and Beacon Financial Group. View Insider Buying and Selling for CVS Health Corporation.

How do I buy CVS Health Corporation stock?

Shares of CVS Health Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CVS Health Corporation's stock price today?

One share of CVS Health Corporation stock can currently be purchased for approximately $74.10.

MarketBeat Community Rating for CVS Health Corporation (NYSE CVS)
Community Ranking:  3.5 out of 5 (star star star half star)
Outperform Votes:  854 (Vote Outperform)
Underperform Votes:  359 (Vote Underperform)
Total Votes:  1,213
MarketBeat's community ratings are surveys of what our community members think about CVS Health Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for CVS Health Corporation (NYSE:CVS) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 7 Hold Ratings, 14 Buy Ratings
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $89.82 (21.21% upside)
Consensus Price Target History for CVS Health Corporation (NYSE:CVS)
Price Target History for CVS Health Corporation (NYSE:CVS)
Analysts' Ratings History for CVS Health Corporation (NYSE:CVS)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/12/2017SunTrust Banks, Inc.Set Price TargetBuy$85.00N/AView Rating Details
10/12/2017Needham & Company LLCReiterated RatingHoldN/AView Rating Details
10/9/2017Oppenheimer Holdings, Inc.Reiterated RatingBuy$95.00N/AView Rating Details
9/19/2017Royal Bank Of CanadaInitiated CoverageOutperform -> Outperform$95.00LowView Rating Details
9/15/2017Jefferies Group LLCBoost Price TargetHold -> Hold$82.00 -> $86.00MediumView Rating Details
8/24/2017Loop CapitalInitiated CoverageHold -> Hold$83.00LowView Rating Details
8/17/2017Citigroup Inc.Lower Price TargetNeutral$88.00 -> $87.00LowView Rating Details
8/14/2017Robert W. BairdReiterated RatingOutperform$90.00LowView Rating Details
8/14/2017Wolfe ResearchDowngradeOutperform -> Market Perform$89.00 -> $82.00LowView Rating Details
7/3/2017GuggenheimReiterated RatingBuyLowView Rating Details
6/27/2017Leerink SwannSet Price TargetBuy$90.00N/AView Rating Details
6/13/2017Cowen and CompanyReiterated RatingOutperform$86.00LowView Rating Details
5/3/2017Evercore ISIReiterated RatingOutperform$87.00 -> $88.00LowView Rating Details
4/27/2017Tigress FinancialInitiated CoverageBuy -> BuyLowView Rating Details
2/28/2017Bank of America CorporationReiterated RatingBuy$106.67N/AView Rating Details
2/8/2017Deutsche Bank AGReiterated RatingHold$88.00N/AView Rating Details
2/6/2017Atlantic SecuritiesDowngradeOverweight -> Neutral$84.00N/AView Rating Details
12/19/2016Credit Suisse GroupReiterated RatingBuyN/AView Rating Details
11/10/2016ArgusReiterated RatingBuy$120.00 -> $85.00N/AView Rating Details
11/9/2016Barclays PLCReiterated RatingBuy$85.00N/AView Rating Details
11/9/2016MizuhoBoost Price TargetBuy$90.00 -> $111.00N/AView Rating Details
9/12/2016Morgan StanleyReiterated RatingHold$104.00N/AView Rating Details
8/3/2016FBR & CoReiterated RatingOutperform$120.00N/AView Rating Details
5/5/2016MacquarieReiterated RatingOutperform$115.00N/AView Rating Details
2/10/2016Goldman Sachs Group, Inc. (The)Boost Price TargetNeutral$106.00 -> $110.00N/AView Rating Details
11/3/2015S&P Equity ResearchUpgradeStrong-Buy$121.00N/AView Rating Details
11/2/2015Raymond James Financial, Inc.Boost Price TargetOutperform$105.00 -> $110.00N/AView Rating Details
11/2/2015BMO Capital MarketsBoost Price TargetOutperform$103.00 -> $113.00N/AView Rating Details
11/2/2015J P Morgan Chase & CoLower Price TargetOverweight$128.00 -> $123.00N/AView Rating Details
(Data available from 10/18/2015 forward)


Earnings History for CVS Health Corporation (NYSE:CVS)
Earnings by Quarter for CVS Health Corporation (NYSE:CVS)
Earnings History by Quarter for CVS Health Corporation (NYSE CVS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/6/2017$1.49N/AView Earnings Details
8/8/2017Q2 2017$1.31$1.33$45.36 billion$45.69 billionViewListenView Earnings Details
5/2/2017Q1 2017$1.10$1.17$44.20 billion$44.51 billionViewListenView Earnings Details
2/9/2017Q416$1.67$1.71$46.56 billion$46.00 billionViewListenView Earnings Details
11/8/2016Q316$1.57$1.64$45.29 billion$44.60 billionViewListenView Earnings Details
8/2/2016Q216$1.30$1.32$44.28 billion$43.70 billionViewN/AView Earnings Details
5/3/2016Q116$1.16$1.18$43.01 billion$43.20 billionViewN/AView Earnings Details
2/9/2016Q415$1.53$1.53$41.12 billion$41.15 billionViewN/AView Earnings Details
10/30/2015Q315$1.29$1.28$37.81 billion$38.50 billionViewListenView Earnings Details
8/4/2015Q215$1.20$1.22$37.18 billion$37.20 billionViewN/AView Earnings Details
5/1/2015Q115$1.08$1.14$35.93 billion$36.30 billionViewN/AView Earnings Details
2/10/2015Q414$1.21$1.21$36.06 billion$37.06 billionViewN/AView Earnings Details
11/4/2014Q314$1.13$1.15$34.74 billion$35.00 billionViewN/AView Earnings Details
8/5/2014Q214$1.10$1.13$33.47 billion$34.60 billionViewN/AView Earnings Details
5/2/2014Q114$1.05$1.02$32.31 billion$32.70 billionViewN/AView Earnings Details
2/11/2014Q413$1.11$1.12$32.67 million$32.80 millionViewN/AView Earnings Details
11/5/2013Q313$1.02$1.05$31.53 billion$32.00 billionViewListenView Earnings Details
8/6/2013Q2 2013$0.96$0.97$31.13 billion$31.25 billionViewListenView Earnings Details
5/1/2013Q113$0.79$0.83$30.36 billion$30.76 billionViewListenView Earnings Details
2/6/2013Q4 2012$1.10$1.14$31.13 billion$31.40 billionViewListenView Earnings Details
11/6/2012Q312$0.84$0.85$30.09 billion$30.23 billionViewN/AView Earnings Details
8/7/2012$0.80$0.81ViewN/AView Earnings Details
5/2/2012$0.63$0.65ViewN/AView Earnings Details
11/3/2011$0.68$0.70ViewN/AView Earnings Details
8/4/2011$0.65$0.65ViewN/AView Earnings Details
5/5/2011$0.55$0.57ViewN/AView Earnings Details
2/3/2011$0.79$0.80ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for CVS Health Corporation (NYSE:CVS)
2017 EPS Consensus Estimate: $5.90
2018 EPS Consensus Estimate: $6.49
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$1.09$1.33$1.18
Q2 20174$1.30$1.32$1.31
Q3 20175$1.47$1.64$1.51
Q4 20175$1.87$1.91$1.89
Q1 20184$1.12$1.49$1.30
Q2 20184$1.43$1.62$1.48
Q3 20183$1.65$1.82$1.73
Q4 20183$1.89$2.05$1.98
Q1 20192$1.24$1.35$1.30
Q2 20192$1.54$1.59$1.57
(Data provided by Zacks Investment Research)


Current Dividend Information for CVS Health Corporation (NYSE:CVS)
Next Dividend:11/3/2017
Annual Dividend:$2.00
Dividend Yield:2.70%
Dividend Growth:23.60% (3 Year Average)
Payout Ratio:39.92% (Trailing 12 Months of Earnings)
34.01% (Based on This Year's Estimates)
31.50% (Based on Next Year's Estimates)
Track Record:9 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for CVS Health Corporation (NYSE:CVS)

Dividend History by Quarter for CVS Health Corporation (NYSE CVS)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for CVS Health Corporation (NYSE:CVS)
Insider Ownership Percentage: 0.61%
Institutional Ownership Percentage: 81.46%
Insider Trades by Quarter for CVS Health Corporation (NYSE:CVS)
Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)
Insider Trades by Quarter for CVS Health Corporation (NYSE:CVS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/2/2017Thomas M MoriartyEVPSell20,547$81.17$1,667,799.99View SEC Filing  
9/18/2017Jonathan C RobertsCOOSell85,743$83.14$7,128,673.02View SEC Filing  
9/15/2017Helena FoulkesEVPSell39,340$81.88$3,221,159.20View SEC Filing  
9/13/2017Larry J MerloInsiderSell241,150$83.07$20,032,330.50View SEC Filing  
9/11/2017David M DentonCFOSell237,078$79.65$18,883,262.70View SEC Filing  
9/11/2017Thomas M MoriartyEVPSell90,267$79.61$7,186,155.87View SEC Filing  
8/16/2017Richard J SwiftDirectorSell2,500$79.62$199,050.00View SEC Filing  
6/26/2017Helena FoulkesEVPSell20,333$80.00$1,626,640.00View SEC Filing  
6/19/2017Helena FoulkesEVPSell20,332$76.98$1,565,157.36View SEC Filing  
6/12/2017David M DentonCFOSell230,510$80.00$18,440,800.00View SEC Filing  
3/21/2017Troyen A BrennanEVPSell23,849$78.73$1,877,631.77View SEC Filing  
3/17/2017Eva C BorattoEVPSell6,029$79.60$479,908.40View SEC Filing  
3/13/2017Andrew SussmanEVPSell14,104$80.40$1,133,961.60View SEC Filing  
3/10/2017David M DentonCFOSell95,618$80.68$7,714,460.24View SEC Filing  
2/16/2017Jonathan C RobertsEVPSell61,196$80.00$4,895,680.00View SEC Filing  
5/5/2016Larry J MerloCEOSell38,247$105.00$4,015,935.00View SEC Filing  
5/5/2016Troyen A BrennanEVPSell7,517$105.00$789,285.00View SEC Filing  
4/1/2016Stephen J GoldEVPSell21,922$105.00$2,301,810.00View SEC Filing  
3/9/2016Larry J MerloCEOSell38,247$100.00$3,824,700.00View SEC Filing  
2/11/2016Jonathan C. RobertsEVPSell23,355$92.86$2,168,745.30View SEC Filing  
2/1/2016Larry J. MerloCEOSell46,393$96.14$4,460,223.02View SEC Filing  
1/11/2016Larry J. MerloCEOSell46,393$95.00$4,407,335.00View SEC Filing  
10/27/2015Troyen A. BrennanEVPSell23,603$105.00$2,478,315.00View SEC Filing  
7/20/2015Eva C BorattoSVPSell22,107$110.34$2,439,286.38View SEC Filing  
7/15/2015Lisa BisacciaEVPSell49,908$110.00$5,489,880.00View SEC Filing  
6/1/2015C David Brown IIDirectorSell10,000$102.57$1,025,700.00View SEC Filing  
5/1/2015C David Brown IIDirectorSell15,000$100.27$1,504,050.00View SEC Filing  
4/10/2015Andrew SussmanEVPSell17,638$102.38$1,805,778.44View SEC Filing  
4/2/2015Troyen A BrennanEVPSell33,384$102.48$3,421,192.32View SEC Filing  
3/23/2015Troyen A BrennanEVPSell33,274$104.94$3,491,773.56View SEC Filing  
3/20/2015C David Brown IIDirectorSell25,000$104.30$2,607,500.00View SEC Filing  
1/7/2015Jonathan C RobertsEVPSell86,487$95.31$8,243,075.97View SEC Filing  
1/5/2015Larry J MerloCEOSell144,144$94.30$13,592,779.20View SEC Filing  
1/2/2015Andrew SussmanSVPSell4,220$95.67$403,727.40View SEC Filing  
1/2/2015Per Gh LofbergEVPSell347,343$95.28$33,094,841.04View SEC Filing  
11/7/2014Helena FoulkesEVPSell46,325$88.06$4,079,379.50View SEC Filing  
10/27/2014Lisa BisacciaSVPSell33,507$85.00$2,848,095.00View SEC Filing  
9/2/2014Andrew SussmanSVPSell9,020$79.45$716,639.00View SEC Filing  
8/6/2014J. David JoynerEVPSell123,516$76.10$9,399,567.60View SEC Filing  
7/21/2014Eva C BorattoSVPSell22,107$76.77$1,697,154.39View SEC Filing  
7/1/2014David M DentonCFOSell74,989$75.88$5,690,165.32View SEC Filing  
4/2/2014Eva BorattoSVPSell17,108$74.51$1,274,717.08View SEC Filing  
3/31/2014Troyen BrennanEVPSell18,867$74.33$1,402,384.11View SEC Filing  
1/3/2014David DentonCFOSell14,113$70.50$994,966.50View SEC Filing  
1/3/2014Per Gh LofbergEVPSell790,888$70.54$55,789,239.52View SEC Filing  
1/2/2014Jonathan RobertsEVPSell162,192$70.61$11,452,377.12View SEC Filing  
1/2/2014Larry MerloCEOSell228,875$70.76$16,195,195.00View SEC Filing  
12/10/2013Lisa BisacciaSVPSell12,057$68.00$819,876.00View SEC Filing  
11/18/2013Troyen BrennanEVPSell35,387$65.61$2,321,741.07View SEC Filing  
10/18/2013Eva C BorattoSVPSell11,053$60.50$668,706.50View SEC Filing  
10/11/2013Eva BorattoSVPSell11,053$59.50$657,653.50View SEC Filing  
9/13/2013Helena FoulkesEVPSell53,546$60.00$3,212,760.00View SEC Filing  
9/9/2013Helena FoulkesEVPSell47,568$58.65$2,789,863.20View SEC Filing  
9/4/2013Andrew SussmanSVPSell9,020$58.36$526,407.20View SEC Filing  
10/4/2012Andrew SussmanSVPSell9,020$49.00$441,980.00View SEC Filing  
10/1/2012Thomas M MoriartyEVPBuy6,164$48.67$300,001.88View SEC Filing  
9/13/2012David M DentonCFOSell11,526$47.00$541,722.00View SEC Filing  
8/21/2012Jean Pierre MillonDirectorSell33,726$45.73$1,542,289.98View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for CVS Health Corporation (NYSE:CVS)
Latest Headlines for CVS Health Corporation (NYSE:CVS)
DateHeadline logoCVS Health Corporation (CVS) Given Average Rating of "Buy" by Analysts - October 18 at 5:06 PM logoCVS Pharmacy Encourages Patients to Check Their Meds on "National Check Your Meds Day" - October 17 at 6:27 PM logoHow Wall Street Analysts View Walgreens and CVS - October 17 at 6:27 PM logoCVS Health and Epic Announce Initiative to Help Lower Drug Costs for Patients by Providing Prescribers with Expanded Visibility to Lower Cost Alternatives - October 16 at 11:26 PM logoTrade of the Week: CVS Health - October 16 at 11:26 PM logoCVS versus Walgreens: Business Health Checkup - October 16 at 11:26 PM logoWalgreens versus CVS: Comparing Near-Term Earnings Potential - October 16 at 11:26 PM logoCVS: Whatever Floats Your Moat - Seeking Alpha - October 16 at 6:25 PM logoTop Losers in the Consumer Sector: October 9–13, 2017 - October 16 at 6:25 PM logoDon't Buy CVS For Your Dividend Growth Portfolio - October 13 at 11:15 PM logoCVS versus Walgreens: Which Has a More Diversified Business Model? - October 13 at 6:14 PM logoCVS: Post Pullback Play - Seeking Alpha - October 13 at 4:34 AM logoBetter Buy: CVS Health Corporation vs. Walgreens Boots Alliance - Motley Fool - October 13 at 4:34 AM logoWBA, CVS Fall on News of Amazon Entering Prescription Drug Market - October 13 at 4:34 AM logoCVS Health Corporation (CVS) Earns Buy Rating from SunTrust Banks, Inc. - October 12 at 7:32 PM logoSilverScript Insurance Company, a CVS Health Company, Introduces New Medicare Prescription Drug Plan Options for 2018 - October 12 at 6:27 PM logoCVS Health Recognizes its 30,000 Pharmacists during American Pharmacists Month - October 12 at 6:27 PM logoCATCH Global Foundation And CVS Health Team Up To Curb Youth E-Cigarette Use - October 12 at 6:27 PM logoAs Power Of Name Brands Wanes, CVS Is Betting On Private Labels To Revive Sales - October 12 at 6:27 PM logoCVS Health Corporation (CVS) Given Hold Rating at Needham & Company LLC - October 12 at 11:38 AM logoBetter Buy: CVS Health Corporation vs. Walgreens Boots Alliance - October 12 at 8:41 AM logoCVS Stopped Selling Tobacco. Will Sugary Items Be Banned Next? - October 11 at 1:29 AM logoIt's Time to Profit From CVS Health Corp (CVS) Stock's "Amazonian ... - - October 10 at 3:25 PM logoExpress Scripts Makes $3.6 Billion Buy As Amazon Threat Looms - October 10 at 3:25 PM logoCVS Health, Express Scripts, Walgreens Shares Crash on Amazon Drugs Threat - October 10 at 3:25 PM logoCVS Health Corp. – Value Analysis (NYSE:CVS) : October 10, 2017 - October 10 at 3:25 PM logoExpress, CVS Spiraling On Possible 'Amazon Wild Card' In Drugs - October 9 at 11:07 PM logoCVS Health Corp. breached its 50 day moving average in a Bearish Manner : CVS-US : October 9, 2017 - October 9 at 6:04 PM logoLeerink Partners Convinced about Amazon’s Entry in the Pharma Space - October 9 at 6:04 PM logoSell CVS, Walgreens on Amazon’s Rx Drug Venture? - October 9 at 6:04 PM logoCVS Health Corporation's (CVS) "Buy" Rating Reiterated at Oppenheimer Holdings, Inc. - October 9 at 3:16 PM logoCVS Health Corporation Target of Unusually High Options Trading (CVS) - October 9 at 8:52 AM logoBest Buy: CVS Health, Walgreens, or Rite Aid? - October 8 at 4:48 PM logoAmazon is on the brink of deciding if it will make a big ... - October 6 at 10:55 PM logoHillman Announces Key Management Change - October 6 at 10:55 PM logoShould You Buy CVS Health Corporation (CVS) At This PE Ratio? - October 6 at 10:55 PM logoDrug chains tumble on reports Amazon eyeing their pie - Reuters - October 6 at 5:54 PM logoCVS Health Is In A Great Position To Excel - Seeking Alpha - October 6 at 5:54 PM logoLeerink Swann Weighs in on CVS Health Corporation's FY2018 Earnings (CVS) - October 6 at 1:16 PM logoLocal Fortune 500 firm appoints CVS executive to its board of directors - October 5 at 4:54 PM logoCVS Pharmacy Introduces ScriptPath™ Prescription Schedule for Patients - October 4 at 11:22 AM logoCVS Health Announces $10 Million Donation Following In-Store Fundraising Campaign For Hurricane Rebuilding Efforts - October 4 at 11:22 AM logoCVS Health Corporation (CVS) EVP Thomas M. Moriarty Sells 20,547 Shares - October 3 at 10:28 PM logoValidea John Neff Strategy Daily Upgrade Report - 10/3/2017 - Nasdaq - October 3 at 6:45 AM logo Brokerages Expect CVS Health Corporation (CVS) Will Post Quarterly Sales of $46.21 Billion - October 2 at 5:40 AM logoCVS Health Corporation (CVS) Expected to Post Earnings of $1.49 Per Share - September 30 at 12:24 PM logoDrug Stores Next On The Amazon Hit List? - September 24 at 4:58 PM logoCVS Health Corporation (CVS) Given Average Rating of "Buy" by Brokerages - September 23 at 2:44 PM logoCVS Health Corporation Shares Cross Below 200 DMA - September 22 at 9:45 PM logo[$$] CVS Insiders Sell $100 Million in Stock - September 22 at 9:44 PM



CVS Health Corporation (CVS) Chart for Wednesday, October, 18, 2017

This page was last updated on 10/18/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.